Global HPV Vaccines Market to Grow Rapidly at a CAGR of ~8% by 2034 | DelveInsight

The global HPV vaccines market is projected to grow from USD 8.9 billion in 2025 to USD 18.4 billion by 2034, driven by rising HPV-associated cancer prevalence, expanding government immunization programs, and advancements in multivalent vaccines. North America leads the market with 41% share, while Asia-Pacific emerges as a significant growth contributor. Key developments include Merck's presentation of long-term vaccine effectiveness data and China's approval of the first domestically-developed 9-valent HPV vaccine.